A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three ...

Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes.Now, a clinical trial suggests the medicines can ...

An early study hints at an intriguing possibility: The weight-loss drug Ozempic might allow people newly diagnosed with Type 1 diabetes to drop their daily insulin shots.

Initially approved to treat Type 2 diabetes, Ozempic and Mounjaro also can help people with Type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Top News U.S. News ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% ...

Patients with type 1 diabetes could possibly cease daily insulin injections thanks to the “miracle” weight loss drug Ozempic originally developed to combat type 2 diabetes, Metro News reported ...

More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study found. Researchers attribute the high demand to rising rates of obesity among people with type 1 diabetes.

Q. I’m a Type 1.5 diabetic (yes, it’s a thing), so I rely on insulin (as if I were a Type 1) plus a couple of medications typically prescribed for Type 2. I need all of them to keep my blood ...

By Meg Tirrell, CNN (CNN) — A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes ...

An early study hints at an intriguing possibility: The weight-loss drug Ozempic might allow people newly diagnosed with Type 1 diabetes to drop their daily insulin shots.